Among these upregulated DEGs from Bace1-null reactive astrocytes, Clu gained our particular attention, because it is highly expressed in astrocytes, is a top GWAS risk factors for the development of AD, and has a known role in clearance of aggregated Aβ [49–52]. This evidence concerns the gene CLU and Alzheimer disease.